• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在不干扰DNA切割、ATP水解或N端夹子运作的情况下,阻碍人类拓扑异构酶IIα的链通过反应。

Hindering the strand passage reaction of human topoisomerase IIalpha without disturbing DNA cleavage, ATP hydrolysis, or the operation of the N-terminal clamp.

作者信息

Oestergaard Vibe H, Giangiacomo Laura, Bjergbaek Lotte, Knudsen Birgitta R, Andersen Anni H

机构信息

Department of Molecular Biology, University of Aarhus, C. F. Møllers Allé, Building 130, 8000 Aarhus C, Denmark.

出版信息

J Biol Chem. 2004 Jul 2;279(27):28093-9. doi: 10.1074/jbc.M402120200. Epub 2004 Apr 28.

DOI:10.1074/jbc.M402120200
PMID:15123700
Abstract

DNA topoisomerase II is an essential enzyme that releases a topological strain in DNA by introduction of transient breaks in one DNA helix through which another helix is passed. While changing DNA topology, ATP is required to drive the enzyme through a series of conformational changes dependent on interdomain communication. We have characterized a human topoisomerase IIalpha enzyme with a two-amino acid insertion at position 351 in the transducer domain. The mutation specifically abolishes the DNA strand passage event of the enzyme, probably because of a sterical hindrance of T-segment transport. Thus, the enzyme fails to decatenate and relax DNA, even though it is fully capable of ATP hydrolysis, closure of the N-terminal clamp, and DNA cleavage. The cleavage activity is increased, suggesting that the transducer domain has a role in regulating DNA cleavage. Furthermore, the enzyme has retained a tendency to increase DNA cleavage upon nucleotide binding and also responds to DNA with elevated ATP hydrolysis. However, the DNA-mediated increase in ATP hydrolysis is lower than that obtained with the wild-type enzyme but similar to that of a cleavage-deficient topoisomerase IIalpha enzyme. Our results strongly suggest that the strand passage event is required for efficient DNA stimulation of topoisomerase II-mediated ATP hydrolysis, whereas the stimulation occurs independent of the DNA cleavage reaction per se. A comparison of the strand passage deficient-enzyme described here and the cleavage-deficient enzyme may have applications in other studies where a clear distinction between strand passage and topoisomerase II-mediated DNA cleavage is desirable.

摘要

DNA拓扑异构酶II是一种必需的酶,它通过在一条DNA螺旋中引入瞬时断裂,使另一条螺旋通过,从而释放DNA中的拓扑张力。在改变DNA拓扑结构时,需要ATP来驱动该酶经历一系列依赖于结构域间通讯的构象变化。我们鉴定了一种人类拓扑异构酶IIα,其在转导结构域的351位有两个氨基酸插入。该突变特异性地消除了该酶的DNA链通过事件,可能是由于T段转运的空间位阻。因此,即使该酶完全能够进行ATP水解、N端夹子的闭合和DNA切割,它也无法解开连环体和松弛DNA。切割活性增加,表明转导结构域在调节DNA切割中起作用。此外,该酶在核苷酸结合后仍保留增加DNA切割的倾向,并且对DNA也有ATP水解升高的反应。然而,DNA介导的ATP水解增加低于野生型酶,但与切割缺陷型拓扑异构酶IIα酶相似。我们的结果强烈表明,链通过事件是拓扑异构酶II介导的ATP水解有效DNA刺激所必需的,而这种刺激独立于DNA切割反应本身而发生。本文所述的链通过缺陷型酶与切割缺陷型酶的比较可能在其他需要明确区分链通过和拓扑异构酶II介导的DNA切割的研究中具有应用价值。

相似文献

1
Hindering the strand passage reaction of human topoisomerase IIalpha without disturbing DNA cleavage, ATP hydrolysis, or the operation of the N-terminal clamp.在不干扰DNA切割、ATP水解或N端夹子运作的情况下,阻碍人类拓扑异构酶IIα的链通过反应。
J Biol Chem. 2004 Jul 2;279(27):28093-9. doi: 10.1074/jbc.M402120200. Epub 2004 Apr 28.
2
Communication between the ATPase and cleavage/religation domains of human topoisomerase IIalpha.人拓扑异构酶IIα的ATP酶结构域与切割/连接结构域之间的通讯
J Biol Chem. 2000 Apr 28;275(17):13041-8. doi: 10.1074/jbc.275.17.13041.
3
The transducer domain is important for clamp operation in human DNA topoisomerase IIalpha.在人类DNA拓扑异构酶IIα中,转导结构域对于钳夹操作很重要。
J Biol Chem. 2004 Jan 16;279(3):1684-91. doi: 10.1074/jbc.M309624200. Epub 2003 Oct 28.
4
The QTK loop is essential for the communication between the N-terminal atpase domain and the central cleavage--ligation region in human topoisomerase IIalpha.QTK环对于人类拓扑异构酶IIα中N端ATP酶结构域与中心切割-连接区域之间的通讯至关重要。
Biochemistry. 2009 Jul 14;48(27):6508-15. doi: 10.1021/bi9005978.
5
A human topoisomerase II alpha heterodimer with only one ATP binding site can go through successive catalytic cycles.仅具有一个ATP结合位点的人拓扑异构酶IIα异二聚体可以经历连续的催化循环。
J Biol Chem. 2003 Feb 21;278(8):5768-74. doi: 10.1074/jbc.M210332200. Epub 2002 Dec 11.
6
The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DNA.C 末端结构域对人源拓扑异构酶 IIα和β与 DNA 相互作用的影响。
PLoS One. 2011 Feb 16;6(2):e14693. doi: 10.1371/journal.pone.0014693.
7
Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.探究细胞毒性双二氧哌嗪ICRF-193与人拓扑异构酶IIα的封闭酶钳的相互作用。
Mol Pharmacol. 2000 Sep;58(3):560-8. doi: 10.1124/mol.58.3.560.
8
The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis.p53肿瘤抑制蛋白通过提高ATP水解速率来刺激人拓扑异构酶IIα的催化活性。
J Biol Chem. 2000 Jun 16;275(24):18503-10. doi: 10.1074/jbc.M002081200.
9
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.新型氧杂蒽酮-多胺共轭物作为人拓扑异构酶IIα的催化抑制剂
Bioorg Med Chem Lett. 2017 Oct 15;27(20):4687-4693. doi: 10.1016/j.bmcl.2017.09.011. Epub 2017 Sep 8.
10
A mutation in human topoisomerase II alpha whose expression is lethal in DNA repair-deficient yeast cells.人类拓扑异构酶IIα中的一种突变,其表达在DNA修复缺陷的酵母细胞中是致死性的。
J Biol Chem. 2004 Jun 18;279(25):25947-54. doi: 10.1074/jbc.M312314200. Epub 2004 Mar 22.

引用本文的文献

1
The significance of Epstein Barr virus (EBV) & DNA topoisomerase II alpha (DNA-Topo II alpha) immunoreactivity in normal oral mucosa, oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC).EBV 与 DNA 拓扑异构酶 IIα 在正常口腔黏膜、口腔上皮异型增生和口腔鳞状细胞癌中的意义。
Diagn Pathol. 2008 Nov 20;3:45. doi: 10.1186/1746-1596-3-45.
2
Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II.杜氏利什曼原虫拓扑异构酶II“Gyr A”部分的DNA结合结构域的表征及活性位点残基的鉴定
Nucleic Acids Res. 2005 Apr 28;33(8):2364-73. doi: 10.1093/nar/gki527. Print 2005.